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Background: The complex of Dock180/ELMO1 that functions as a bipartite guanine nucleotide exchange factor for
Rac is essential for diverse physiological and pathological processes of cells such as cell migration, phagocytosis,
and invasion of cancer cells. Among the Src-family tyrosine kinases (SFKs), it has been reported that Hck directly
phosphorylates ELMO1, regulating phagocytosis by promoting activation of Rac1; however, the involvement of
other SFKs in ELMO1 phosphorylation has remained unknown. Here, we identified novel tyrosine (Y) residues of
ELMO1 phosphorylated by SFKs, and examined the effects on Rac1 activity, cell adhesion, spreading, and cell
motility on extracellular matrix (ECM).
Results: In this study, we unveiled that Src and Fyn can induce tyrosine phosphorylation of ELMO1 in in vivo and
in vitro phosphorylation assays. Mutational analyses identified both Y720 and Y724 residues of ELMO1 as Src-mediated
phosphorylation sites, preferentially on Y724. Single substitution of Y724 to Phe abrogated Rac1 activation triggered by
Src. To elucidate the biological function of pY724, we established NIH3T3 cells stably expressing wild-type ELMO1 or its
Y724F mutant together with Dock180. Among them, Y724-deficient cells exhibited a depletion of Rac1 activity
with diminished phosphorylation of ELMO1 even upon the ECM-stimulation. It is noteworthy that NIH3T3 cells
with ELMO1 Y724F were strikingly defective to promote cell spreading on fibronectin-coated dish, concomitantly
exhibiting immature assemblies of actin stress fibers and focal adhesions. Eventually, ELMO1 Y724F significantly
impaired cell migration.
Conclusion: These results define that Src-mediated Y724 phosphorylation in ELMO1 plays a critical role for cell
spreading via activation of Rac1, leading to promotion of cell migration. As the overexpression and/or hyperactivation
of Src have been shown in a wide variety of human cancers, Src-mediated phosphorylation of Y724 in ELMO1 may
regulate cancer cell adhesion to the ECM, invasion into surrounding tissues, and subsequent distant metastasis.
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Cell migration is essential for a wide variety of physio-
logical and pathological processes, including embryonic
development, wound repair, inflammatory responses, and
tumor metastases. Signalling adaptor protein Crk that is
bound to Dock180 (downstream of Crk with 180 kDa) has* Correspondence: tanaka@med.hokudai.ac.jp
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creativecommons.org/publicdomain/zero/1.0/been shown to be one of the essential molecules to regu-
late focal adhesion. Tyrosine kinases including Fak or
components of focal adhesion such as p130Cas are conven-
tional upstream regulators of Dock180 through the
binding to Crk. Currently, the trimolecular complex
known as Crk/Dock180/ELMO1 (regulator of engulf-
ment and motility 1) complex plays a pivotal role in cell
migration [1, 2]. ELMO1 was originally identified as the
Dock180 binding protein regulating engulfment and
cell migration in nematodes, and currently it is known
that Dock180/ELMO1 functions as a bipartite guaninerticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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Rac1 and regulates cytoskeletal remodeling [3].
ELMO1 possesses a pleckstrin homology (PH) domain
and proline-rich motif residing in its C-terminus [4, 5],
but has no catalytic domain. Through its proline-rich
motif, ELMO1 binds to the SH3 domain of Dock180
and enhances GEF activity of Dock180 by relieving the
inhibitory loop of Dock180 per se [6]. It has been re-
cently reported that the atypical PH domain of ELMO1
directly interacts with Dock180 in a Rac-independent
and constitutive manner [7]. In addition, small GTPase
RhoG directly binds to Armadillo (ARM) repeats of
ELMO1 at the N-terminus, and the ternary complex
comprised of RhoG, ELMO1, and Dock180 may activate
Rac1 at the plasma membrane, resulting in integrin-
mediated cell spreading, phagocytosis, and nerve growth
factor (NGF)-induced neurite outgrowth [8, 9].
ELMO1/Dock180 complex is implicated in pathogen-
esis of various diseases such as diabetic nephropathy,
HIV infection, and tumor development [10, 11]. Espe-
cially, enhanced expression of ELMO1/Dock180 complex
together with Crk is evidently linked to the invasiveness of
brain tumors [12] and ovarian cancers [13]. Protein levels
of Dock180 are possibly controlled by ELMO1, in which
ELMO1 inhibits ubiquitylation of Dock180 and prevents
proteasome-dependent degradation of Dock180 through
the direct interaction [14].
Although ELMO1 is essential for the activation of
Dock180, the mechanism regulating the activity of
ELMO1 has remained obscure. Intriguingly, it has been
reported that ELMO1 directly binds to the SH3 domain
of hematopoietic cell kinase (Hck), a member of the Src
family of protein tyrosine kinases (SFKs) via its proline-
rich motif, and the subsequent phosphorylation on Y511
of ELMO1 by Hck plays an important role in cell migra-
tion and phagocytosis [15, 16]. Recently, the receptor
tyrosine kinase Axl also phosphorylates ELMO, and pro-
motes Rac activation and cell invasion [17].
SFKs are non-receptor tyrosine kinases involved in
various signalling pathways including cell proliferation,
migration, adhesion, and angiogenesis [18, 19]. Over-
expression and/or activation of Src have been fre-
quently detected in a variety of tumors arising from
the lung, breast, colon, prostate, and pancreas [18, 20],
and hyperactivity of Src is correlated with tumor progres-
sion, metastasis, and poor prognosis [21]. These evidences
indicate the significance of Src-mediated signalling path-
ways in the development and progression of human
cancers.
In this study, we demonstrated that Src contributed to
tyrosine phosphorylation of ELMO1 at Y720 and Y724
residues, which was crucial for activation of Rac1,
followed by the promoting cell adhesion, spreading, and
migration.Results
Tyrosine phosphorylation of ELMO1 by SFKs
To explore a potential of SFKs on ELMO1 phosphoryl-
ation, each of SFK such as Src, Yes, Fyn, Lyn, Lck, and
Hck was co-expressed with ELMO1 in 293 T cells. Anti-
non-phospho-Src Y416 antibody recognizes conserved
region of SFKs, which certified that equivalent amounts
of SFKs such as Src, Fyn, Yes, Lck, Lyn, and Hck were
overexpressed in 293 T cells (Fig. 1a). Under this condi-
tion, ELMO1 was remarkably phosphorylated in the
presence of Src and Fyn, in addition to Hck (Fig. 1a),
compared to the other kinases. Magnitude of tyrosine
phosphorylation of ELMO1 is not completely correlated
to the tyrosine phosphorylation levels of total cell lysates
(Fig. 1a, lower panel). As Src has been reported to be
overexpressed in several human cancers, we focused on
Src and examined whether Src directly phosphorylates
ELMO1 by in vitro kinase assay using GST-ELMO1 as a
substrate. ELMO1 could be tyrosine-phosphorylated by
Src without an association with Dock180 (Fig. 1b).
Tyrosine 724 of ELMO1 is a phosphorylation site by Src
To identify the Src-mediated phosphorylation site of
ELMO1, we constructed a series of mutants of ELMO1.
Among 19 tyrosine residues in ELMO1, ten of them
(Y60, 216, 352, 356, 395, 511, 646, 662, 720, and 724)
satisfy criteria for potential Src-, but not SFKs-,
dependent phosphorylation sites according to the prediction
service of phosphorylation (NetPhos service, CBS Prediction
Servers, Technical Univ. of Denmark, http://www.cbs.dtu.
dk/services/NetPhos/, Additional file 1: Table S1). Thus,
these tyrosine residues of ELMO1 were individually
substituted by phenylalanine (Fig. 2a, upper) and coex-
pressed with a constitutively active form of Src (Src Y527F)
in 293 T cells. Tyrosine phosphorylation levels of ELMO1
Y724F mutant was markedly reduced compared to that of
wild-type ELMO1 (Fig. 2b). The phosphorylation level of
the Y720F mutant was also attenuated, albeit to a lesser ex-
tent, whereas phenylalanine substitution for other tyrosine
residues of ELMO1 showed no reduction of phosphoryl-
ation (Fig. 2b). It should be noted that Src-dependent
tyrosine phosphorylation of ELMO1 Y511F was not de-
creased (Fig. 2b), although this Y511 residue has been
reported to be phosphorylated by Hck [15]. Src-mediated
phosphorylation of ELMO1 was remarkably decreased by
the Y724F mutation (Fig. 2c). As Hck-dependent phos-
phorylation of ELMO1 was also partially decreased by
Y724F mutation (Fig. 2c), which suggests that Hck can
phosphorylate Y724, in addition to previously identified
pY site as Y511.
To elucidate the mechanism underlying phosphoryl-
ation of ELMO1 by Src, we generated a deletion mu-
tant of ELMO1 lacking N-terminal 662 amino acids
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Fig. 1 Phosphorylation of ELMO1 by Src. a In vivo phosphorylation of ELMO1 by SFKs. HEK293T cells were transfected with pCXN2-Flag-ELMO1
in combination with plasmids expressing SFKs: Src, Fyn, Yes, Lck, Lyn, and Hck. Lysates from these cells were subjected to immunoprecipitation
with anti-Flag antibody (Ab) for ELMO1, followed by immunoblotting with Ab to phosphotyrosine (PY). Anti-non-phospho-Src Y416 antibody
recognizes conserved region of other SFKs such as Lyn, Fyn, Lck, Yes, and Hck. IP: immunoprecipitation, TCL: Total Cell Lysate, pELMO1:
tyrosine phosphorylated ELMO1, pSFKs: phosphorylated SFKs. b In vitro phosphorylation of ELMO1 by Src. Recombinant proteins of c-Src
and GST-ELMO1 were mixed with or without ATP for kinase reaction. Reaction samples were analyzed by immunoblotting with Abs
against PY (upper) and GST (lower). Auto-pSrc: autophosphorylated Src
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Thereafter, two tyrosine residues Y720 and Y724 in
GST-ELMO1Δ662 were substituted by phenylalanine
individually or simultaneously (GST-ELMO1Δ662-Y720F,
Δ662-Y724F, and Δ662-Y720/724 F). In single substitu-
tional mutant such as Y720F or Y724F, the phosphoryl-
ation levels remarkably decreased but still remained,
whereas their double mutant as Y720F/Y724F completely
abrogated the phosphorylation, suggesting the both Tyr
residues can be phosphorylated by Src (Fig. 2d).
Requirement for Y724 phosphorylation of ELMO1 in Src-
dependent Rac1 activation
We next examined the contribution of ELMO1 phos-
phorylation to Rac1 activation. Under an intrinsic ex-
pression of Src in 293 T cells, co-forced expressions of
Dock180 and wild-type ELMO1 enhanced Rac1 activity
(Fig. 3, lane 1 vs 2) as reported previously [3]. This
activation was not markedly affected by Y724F substitu-
tion of ELMO1 (Fig. 3, lane 3), nor by all of the other
substitutions (Additional file 2: Figure S1). Meanwhile,
upon an introduction of active SrcY527F (Fig. 3, lanes
4–6), forced expression of wild-type ELMO1 could not
enhance Rac1 activity (Fig. 3, lane 4 vs 5), due to pre-
sumably maximum activation of endogenous Rac1 upon
Src activation. In this context, ELMO1-Y724F signifi-
cantly suppressed Rac1 activity (Fig. 3, lane 6), suggest-
ing the pivotal role of pY724 of ELMO1 in Src-triggered
activation of Rac1. Of note, the amount of Dock180
protein was up-regulated in the presence of exogenousELMO1 (Fig. 3), which may be due to inhibition of ubi-
quitination of Dock180 through the interaction with
ELMO1, as we have reported previously [14].
Establishment of NIH3T3 cell lines constitutively
expressing Dock180/ELMO1 or Dock180/ELMO1 Y724F
To investigate the role of ELMO1 phosphorylation in
biological responses, we established NIH3T3 cells con-
stitutively expressing both Dock180 and wild-type
ELMO1, or both Dock180 and ELMO1 Y724F mutant
(Fig. 4a). To confirm the relevance of pY724 of ELMO1
for Rac1 activity in these cells, Rac1 activity upon cell
adhesion to the fibronectin-coated dish was examined
because fibronectin-induced integrin signalling has been
shown to be mediated through the Src, Dock180, and
the ELMO1-dependent pathway [22]. The phosphoryl-
ation of ELMO1, together with subsequent activation of
Rac1, could be observed in NIH3T3 cells expressing
wild-type ELMO1, but not the ELMO1 Y724F mutant
(Fig. 4b).
Requirement for phosphorylation of ELMO1 Y724 in cell
spreading and adhesion
Under a forced expression of Dock180, the cells with ex-
trinsic wild-type ELMO1 displayed an enlarged cytoplasm
with the frequent appearance of membrane ruffles (Fig. 5a,
black arrowheads). No significant difference was observed
between control cells and the Y724F mutant, except for
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Fig. 2 Tyr724 residue of ELMO1 is a phosphorylation site by Src. a Schematic representations show ELMO1 protein with the tyrosine residues
mutated (from tyrosine to phenylalanine residue, Y60F, Y216F, Y352F, Y356F, Y395F, Y511F, Y646F, Y662F, Y720F, Y724F, upper), and its deletion
mutant (663–727 amino acids) fused with GST (lower). PH: Pleckstrin Homology domain, PxxP: proline-rich motif. b In vivo phosphorylation of
ELMO1 mutants by Src. HEK293T cells were transfected with either pCMV-Myc-ELMO1 or its defective mutants on tyrosine, together with pCXN2-Flag-Src
Y527F. Lysates from these cells were subjected to immunoprecipitation with anti-Myc Ab for ELMO1, followed by immunoblotting with Abs to PY (upper)
and Myc (middle). Expression of extrinsic Src was also examined using anti-Flag Ab (lower). c In vivo phosphorylation of ELMO1 Y724F mutant by Src and
Hck. Lysates from HEK293T cells expressing Flag-tagged ELMO1 and its Y724F mutant in the presence or absence of Src and Hck were subjected to
immunoprecipitation and immunoblot analyses. d In vivo phosphorylation of ELMO1Δ662 by Src. HEK293T cells were transfected with pEBG-ELMO1Δ662
and its mutant forms (Y720F, Y724F, Y720/724 F), together with pMik-Src Y527F. Lysates from the cells were subjected to the pull-down assay with
glutathione-sepharose beads, followed by immunoblotting with Abs to PY (top) and GST (middle). Expression levels of Src (intrinsic Src and its extrinsic
Y527F) were examined using anti-Src Ab (bottom). GST-ELMO1Δ662: ELMO1Δ662 fused with GST
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changes were analyzed by time-lapse imaging. Speed and
extent of cell spreading on the fibronectin-coated dish was
remarkably facilitated by wild-type ELMO1 (Fig. 5b,
Additional file 3: Movie S1 vs Additional file 4: Movie S2).
Only random and transient protrusions of the cell
membrane were observed in the Y724F cells (Fig. 5b,
Additional file 5: Movie S3). Actin staining of the cellsat 30 min after the plating revealed that the size of
spread cell became significantly larger by wild-type
ELMO1 (Figs. 5c,d upper panel). Focal adhesions were
strongly developed at the end of actin stress fibers in
the cells with wild-type ELMO1; indeed, the numbers
of focal adhesions, as visualized with an anti-paxillin
antibody, were 2.6-fold higher than those in control
cells (Figs. 5e,d lower panel). The cells with ELMO1
GTP-Rac1  
IB: Rac1  
IB: Dock180  
IB: ELMO1  
IB: Src
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Fig. 3 Involvement of ELMO1 pY724 on Rac1 activation triggered by
Src. Plasmids for expressing Flag-Dock180, Src Y527F, Myc-ELMO1
and its Y724F mutant were introduced in HEK293T cells as indicated.
The lysates were subjected to pull-down assay for Rac1 activity.
Expression levels of total Rac1, Dock180, ELMO1, and Src were also
examined by immunoblotting. Actin was a loading control. This
experiment was repeated for 4 times
IB: Dock18
IB: ELMO1















Fig. 4 Establishment of NIH3T3-Dock180-ELMO1 cells. a NIH3T3 cells stably
wild-type ELMO1 and its Y724F mutant, and the introduced cells were sele
were examined by immunoblotting using Abs to Flag and ELMO1, respective
ELMO1 cells. Trypsinized NIH3T3-Dock180-ELMO1 cells were replaced ont
phosphorylation of ELMO1, immunoprecipitation and the subsequent immun
(upper two panels). For Rac1 activity, the cell lysates were subjected to th
Ab (bottom two panels)
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faint staining for paxillin (Figs. 5d,e). In agreement with
these findings, the ability of cell adhesion was signifi-
cantly up-regulated by the expression of wild-type
ELMO1, on extracellular matrices such as fibronectin
(Fig. 5f ). Taken together, the pY724 of ELMO1 plays a
critical role in organizations of the actin cytoskeleton
and focal adhesion, and the subsequent cell adhesion.Y724 phosphorylation of ELMO1 facilitates cell migration
To clarify whether pY724 of ELMO1 is involved in cell
migration, we performed a trans-well migration assay
using Boyden chamber in NIH3T3 cells with wild-type
ELMO1 or its Y724F mutant, upon extrinsic Dock180
expression. We succeeded to detect the strikingly
enhancement of the motility upon WT-ELMO1 expres-
sion, and significant decrease by the Y724F mutation
(Figs. 6a,b). It should be noted that in wound healing
assay, we could not observe the inhibitory effect by the
Y724F mutant, with or without extrinsic Dock180
(Additional file 6: Figure S2, Additional file 7: Text S1,
and Additional file 8: Figure S3). We also performed a
phagokinetic track assay to visualize the random motil-
ity at a single cell level (Additional file 7: Text S1).
Forced expression of wild-type ELMO1 did not en-
hance cell motility (Additional file 9: Figure S4), indi-
cating the sufficient amount of intrinsic ELMO1 for
collaborating with Dock180 under this condition. Mean-
while, the cells with ELMO1 Y724F mutant significantly
reduced cell migration regardless of fibronectin coating
(Additional file 9: Figure S4).0  
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Fig. 5 Phosphorylation of ELMO1 Y724 contributes to the enhancement of cell adhesion. NIH3T3-Dock180-Control, −wild-type ELMO1, and - Y724F
ELMO1 cells were employed throughout the analyses in Fig. 4. a Representative cell morphologies onto the conventional culture dish are shown. Black
and white arrowheads indicate the apparent membrane ruffles and the protrusion of the cell membrane, respectively. b-d The trypsinized cells were
replaced onto glass-based dishes coated with 10 μg/ml fibronectin. b Immediately after re-plating, DIC images of cells were obtained every
one minute for 1 h using a time-lapse imaging system. The micrographs after 30 min are shown. To define the cell size, the margins of several
cells are marked with dotted lines. c Cells at 30 min after re-plating were subjected to actin staining. d In immunofluorescence described in Fig. 5c and
5e, the sizes of the individual cells (left panel) and the numbers of paxillin (right panel) were determined using MetaMorph software and manually,
respectively. The data are shown as mean ± SD of six cells from a single experiment. *, P < 0.001; **, P < 0.00001. e Cells at 30 min after re-plating were
subjected to immunofluorescence analysis with Ab to paxillin and with phalloidin for actin staining. In D, representative micrographs are shown and
the merged images placed at the right. f The cells were replaced onto the 96-well plates coated with fibronectin. After incubation for 90 min, the
bound cells were stained, lysed, and measured as described in Materials and Methods. The data are shown as mean ± SD of 3 wells on each condition.
*, P < 0.005; **, P < 0.0001
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ELMO1 has been shown to functionally cooperate with
CrkII and Dock180 to regulate Rac1 activity during cell
migration and phagocytosis [3]. In the present study, wehave demonstrated that Src-mediated phosphorylation of
Y724 of ELMO1 regulates Rac1 activation, and promotes
cell adhesion and motility. Whereas forced expression of




















Control WT Y724F 
Fig. 6 ELMO1 pY724 facilitates cell migration. a Trans-well migration
assay. NIH3T3-Dock180-Control, −wild-type ELMO1, and -Y724F
ELMO1 cells were suspended in DMEM without FBS were seeded
into the upper chamber. DMEM containing 10 % FBS was added to
the lower chamber. After 11 h, migrating cells were stained with
0.04 % crystal violet. Representative micrographs after incubation for
11 h are shown. b The motility of the individual cells was evaluated
by measuring the migrating cells. The data are shown as mean ± SD.
**, P < 0.005; ***, P < 0.0005
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residue of ELMO1 as a preferential phosphorylation sites
by Src.
The significance of the complex formation of ELMO1
and Dock180 in Rac1 activation has been reported. Pre-
vious study disclosed the C-terminal polyproline region
of ELMO1 (707 to 714 amino acids) essentially interacts
with the SH3 domain of Dock180 [6]. This region may
serve also as a potential binding site for Src through its
SH3 domain. Indeed, the C-terminal region of ELMO1
(663–724) is sufficient to be phosphorylated by Src
(Fig. 2d). The phosphorylation of Y724 evoked by Src
might be dispensable for the binding of ELMO1 and
Dock180, because ELMO1 appeared to be able to form
the complex with Dock180 in the absence of active Src
(Fig. 3), in which ELMO1 received no phosphorylation
(Fig. 2c). In fact, an accumulation of Dock180 was ob-
served upon co-expression of ELMO1 and Dock180 in a
Src-independent fashion, irrespective of the phosphor-
ylation status of Y724 (Fig. 3, lanes 1–3). These results
indicate the prevention of Dock180 ubiquitination
owing to the interaction with ELMO1, as we have re-
ported [14].
We demonstrated that phosphorylation of Y720 and
Y724 seem to be reciprocally dependent on each other
(Fig. 2d). Because the pY720 provides the SH2 binding
sequence (pTyr-Asp-Phe-Val), SFK including Src bindsto pY720 and progressively phosphorylates Y724 of
ELMO1 (Additional file 10: Figure S5). In agreement
with this consideration, Y724F mutation may influence
on the phosphorylation status of Y720, and thereby we
should pay attention to this point in any mutational ana-
lysis. Meanwhile, the Hck was previously reported to
phosphorylate Y511 of ELMO1, but as the expression of
Hck is restricted in hematopoietic lineages, a tissue-
specific phosphorylation mode of ELMO1 may be
present. Ultimately, different SFKs could regulate dis-
tinct cellular functions in diverse cell types through
ELMO1 phosphorylation. The detailed molecular mech-
anism(s) underlying how the phosphorylation at the
C-terminus of ELMO1 augments Rac1 activity remains
to be investigated in the future. We are hypothesizing
that phosphorylated ELMO1 recruits additional elements
such as Crk and ERM, and modulates downstream signal-
ing of Rac1 [23].
Disregulation of Src has been observed in a variety of
human malignancies [21]. It has been proposed that Src
functions in cooperation with diverse signalling derived
from tumor microenvironment [24]. It is well estab-
lished that the extracellular matrix (ECM) contributes
to the invasion of tumor cells, in which cell-to-ECM
adhesion through integrins is the first crucial step. In
this context, Src plays a prominent role in the regula-
tion of cell adhesion, migration, and invasion via inter-
action with integrins, Rho GTPase, and focal adhesion
components including p130Cas, paxillin, and FAK [22].
Specifically, signals derived from αvβ5 and β1 integrins
have been shown to induce Src-dependent phosphoryl-
ation of p130Cas , which leads to the recruitment of CrkII/
Dock180 complex and subsequent Rac activation [25–27].
Our observation may provide an additional molecular
mechanism underlying the Src mediated local activation
of Rac1. Corresponding to Src activity arising from ECM
adhesion, Dock180 is recruited, and Dock180 is further
activated through Src-dependent phosphorylation on
Y724 of ELMO1, which may contribute to achieve highly
polarized Rac activity (Additional file 9: Figure S4). In fact,
it was reported that in migrating or PDGF-stimulated
cells, the gradient of Rac activity is more polarized com-
pared to that of Src, despite the Src-Rac hierarchy in their
regulation [28]. Meanwhile, a ternary complex comprised
of RhoG-ELMO1-Dock180 mediates integrin-induced cell
spreading of HeLa cells [29]. As RhoG recruits ELMO1/
Dock180 complex at plasma membrane for efficient Rac1-
dependent cell spreading on fibronectin [9, 30], the facili-
tation of the complex formation owing to Src-dependent
pY724 of ELMO1 might be beneficial to rapid response to
integrin stimulation (Additional file 10: Figure S5).
For tumor microenvironment, the stromal cells were
approved as an ideal source of exogenous stimuli for
tumor cells by producing numerous cytokines, steroid
Makino et al. Cell Communication and Signaling  (2015) 13:35 Page 8 of 11hormones, and other extrinsic factors that affect cancer
cell motility. As these extrinsic factors could induce the
activation of Src [22, 31], they might also enhance mi-
gration of tumor cells through possible Y724 phosphor-
ylation of ELMO1.
On the other hand, the ELMO1/Dock180 complex is
an important regulator of Rac1 activation in endothelial
cells in vitro and during the formation of the vasculature
in zebrafish in vivo [32]. These findings might represent
the consequence of this complex also in cell adhesion
and migration of endothelial cells during tumor angio-
genesis, because an activation of Src has shown in endo-
thelial cells of tumor tissues.
Recent studies highlight Src as a potent target for thera-
peutic intervention; especially as the targeting can over-
come multiple mechanisms of trastuzumab resistance in
breast cancer therapeutics, because hyperactivation of Src
is universally detected in the resistant cells [31, 33]. As an
activation of Src leads to an elevation of the complex con-
sisting of p130Cas/Crk/Dock180 in breast cancer cells [34],
ELMO1/Dock180 binding must be important for produ-
cing Src-dependent activation of Rac1. Because aberrant
activation of cell motility pathways may underlie the var-
iety in cancer cell invasion, the elucidation of mechanisms
underlying ELMO1 pY724-mediated promotion in Rac ac-
tivity might establish these molecules as potential targets
for effective cancer therapies.Conclusions
In summary, we provide evidences that Src-mediated
tyrosine phosphorylation of ELMO1 at Y720 and Y724
residues, which is crucial for activation of Rac1, and sub-
sequent cell adhesion, spreading, and migration. As the
overexpression and/or hyperactivation of Src have been
shown in a wide variety of human cancers, Src-mediated
phosphorylation of Y724 in ELMO1 may regulate cancer
cell adhesion to the extracellular matrix, invasion into
surrounding tissues, and subsequent distant metastasis.Materials and methods
Cell culture
HEK293T and NIH3T3 cells were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM, Nissui, Japan) supple-
mented with 10 % fetal bovine serum (FBS, Biosource,
Camarillo, CA, USA) (complete DMEM). NIH3T3 cells
expressing Dock180 and ELMO1 were maintained in
complete DMEM with 500 μg/ml G418 (Sigma, St. Louis,
MO, USA) and 10 μg/ml Blasticidin S-HCl (Invitrogen,
Carlsbad, CA, USA), respectively, and cells expressing
both Dock180 and ELMO1 were maintained in complete
DMEM containing both of the antibiotics. All cells were
maintained under conditions of 5 % CO2 at 37 °C.Antibodies and immunoblotting
Antibodies were purchased from suppliers as follows:
antibodies to Flag (M2PO) were from Sigma; those to
phosphotyrosine (PY20H) and Rac1 (102) were from BD
Transduction Laboratories (Lexington, KY, USA); those
to GST was from GE Healthcare (Buckinghamshire,
UK); those to actin (C4) was from Chemicon Inter-
national (Temecula, CA, USA); those to Src (GD11) was
from Upstate Biotechnology (Lake Placid, NY, USA);
those to non-phospho-Src Y416 was from Cell Signaling
Technology (Beverly, MA, USA); those to Myc (9E10)
was from Invitrogen; and those to Elmo1 (clone ab2239)
was from Abcam (Cambridge, UK). Immunoblotting was
performed as described previously [14].
Plasmids
pCXN2-Flag-Dock180 and pEBB-Flag-Elmo1 were kind
gifts from Dr. M. Matsuda (Kyoto Univ., Kyoto, Japan) and
Dr. KS. Ravichandran (Univ. of Virginia, Charlottesville,
VA, USA), respectively. pCXbsr and pCLEco were from
Dr. T. Akagi (Kan Institute, Japan), and pMik-Src and
pMik-Src-Y527F, and mammalian expression plasmids
for Fyn, Yes, Lck, Lyn, Hck were from Dr. H. Hanafusa
(Rockefeller Univ., NY, USA). pCMV-myc-Elmo1 was
constructed as described previously [14]. The mutant
forms of pCMV-myc-Elmo1 such as Y60F, Y216F, Y352F,
Y356F, Y395F, Y511F, Y646F, Y662F, Y720F, Y724F and
Y720/724 F (double mutant) were constructed by reverse-
PCR-based method using pCMV-myc-Elmo1 as a tem-
plate. The cDNA of Elmo1 and Src Y527F were amplified
by PCR using pEBB-Flag-ELMO1 and pMik-Src Y527F as
a template, respectively, and subcloned into pCXN2-Flag
and pGEX vectors at XhoI/NotI sites; the resulting
plasmids were named pCXN2-Flag-Elmo1, pGEX-Elmo1,
and pCXN2-Flag-Src Y527F. The DNA fragments encod-
ing 663–727 amino acid of Elmo1 were amplified by PCR
from pCMV-myc-Elmo1 and its mutant forms of Y720F,
Y724F, and Y720/724 F as a template, and inserted
into pEBG vector at XhoI/NotI sites, and the resultant
plasmids were named pEBG-ElmoΔ662, ElmoΔ662-
Y720F, −Y724F, and -Y720/724 F. The cDNA of wild-
type Elmo1 and its Y724F mutant amplified by PCR
were subcloned into pCXbsr vector at BamHI/NotI
sites, and the resultant constructs were named pCXbsr-
Elmo1 and -Elmo Y724F. All PCR fragments were verified
by sequencing.
Establishment of NIH3T3 cell lines expressing Dock180,
ELMO1, and both Dock180 and ELMO1
NIH3T3 cells were transfected with pCXN2-Flag-Dock180
using Lipofectamine 2000 (Invitrogen), and selected by
500 μg/ml G418 (Sigma). The obtained clones were
screened by immunoblot analysis using anti-Flag anti-
body, and the successfully resulting cell line constitutively
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tablish NIH3T3 cells expressing wild-type ELMO1 and its
Y724F mutant, BOSC23 cells were transfected with
pCXbsr-empty, −Elmo1, or -Elmo1 Y724F in combination
with pCLEco vector, and the supernatant containing the
corresponding retroviruses were inoculated to NIH3T3
and NIH3T3-Dock180 cells. Cells were then incubated in
the presence of 10 μg/ml Blasticidin S-HCl, and the
established cell lines were named NIH3T3-Control,
NIH3T3-ELMO1 wild type, NIH3T3-ELMO1 Y724F,
and NIH3T3-Dock180/Control, NIH3T3-Dock180/ELMO1
wild type, NIH3T3-Dock180/ELMO1 Y724F. The ex-
pression levels of exogenous proteins were verified by
immunoblotting.
Detection for tyrosine phosphorylation of ELMO1 in vitro
and in vivo
For in vitro phosphorylation assay, recombinant proteins
of both c-Src (Invitrogen) and ELMO1 which was
purified from the E.coli BL21 strain transformed with
pGEX-ELMO1, were mixed in kinase buffer (40 mM
HEPES-NaOH (pH 7.4), 10 mM MgCl2, 1 mM DTT,
with or without 10 μM ATP), and incubated at 25 °C for
5 min. ELMO1 phosphorylated by c-Src was detected by
immunoblotting with anti-phosphotyrosine antibody.
For in vivo phosphorylation assay, HEK293T cells were
transfected with the plasmids expressing ELMO1 and
one of the Src family kinases. After 48 h, the cells were
lysed and subjected into immunoprecipitation with
antibodies to Flag, Myc, or ELMO1, and the precipi-
tants were analyzed by immunoblotting using anti-
phosphotyrosine antibody.
Pull-down assay for Rac1 activity
HEK293T cells were lysed with buffer containing 1 %
NP-40, 25 mM HEPES (pH 7.4), 150 mM NaCl, 10 %
(v/v) glycerol, 1 mM EDTA, 10 mM MgCl2, 1 mM
PMSF, and a complete protease inhibitor cocktail, and
the lysates were centrifuged at 12,000 rpm at 4 °C for
1 min. The supernatants were incubated with 10 μg of
purified GST-PAK2-RBD, and then with glutathione-
Sepharose 4B beads (GE Healthcare, Little Chalfont,
UK). Following the washing of beads three times, the
precipitants were analyzed by immunoblotting with
anti-Rac1 antibody.
Cell spreading assay by time lapse imaging and
immunofluorescence
NIH3T3-Dock180-Control, NIH3T3-ELMO1 wild type,
or NIH3T3-ELMO1 Y724F cells were trypsinized and sus-
pended in complete DMEM for 30 min. The cells were
subsequently seeded onto fibronectin-coated glass-based
dishes. Cell spreading was evaluated by time-lapse-based
imaging technique and immunofluorescence.For time-lapse imaging analysis, immediately after cell
inoculation, differential interference contrast (DIC) im-
ages of the cells were obtained every one minute for 1 h
using a time-lapse system of an Olympus IX-70 inverted
microscope (Tokyo, Japan), a Photometrics cooled
charge-coupled device camera (Tucson, AZ, USA), and a
Ludl mechanical shutter, which were controlled by
MetaMorph software (Universal Imaging, Downingtown,
PA, USA).
For immunofluorescence analysis, after 30 min of cell
plating, the fixation and staining for actin and paxillin
were performed as described previously [35]. Fluores-
cence images were obtained using a confocal laser-
scanning microscope (FV-300; Olympus, Tokyo, Japan).
The spreading area of the cells was analyzed by Meta-
Morph software and the numbers of positive dots of
paxillin staining were manually counted.
Cell adhesion assay
The NIH3T3 cells utilized in cell spreading assay were
also employed for cell adhesion analysis. 2 × 104 cells
suspended in DMEM containing 0.02 % bovine serum
albumin (BSA) were plated into each well of a 96-well
microplate coated with 10 μg/ml fibronectin (Biomedical
Technologies Inc., Stoughton, MA, USA). After incuba-
tion at 37 °C for 90 min under a humidified atmosphere
containing 5 % CO2, the bound cells were stained with
0.04 % crystal-violet in DMSO, and quantified by measur-
ing the absorbance at 595 nm wave with a spectropho-
tometer (Thermo Electron Corporation, Vantaa, Finland).
Trans-well migration assay
For the trans-well migration assay using Boyden chamber,
2.5 × 104 cells of NIH3T3-Dock180-Control, NIH3T3-
Dock180-ELMO1 wild type, or NIH3T3-Dock180-ELMO1
Y724F were suspended in DMEM without FBS were seeded
into the upper chamber. DMEM containing 10 % FBS was
added to the lower chamber as chemoattractant. After in-
cubation for 11 h, the non-migrating cells on the upper sur-
face of the filters were removed by a wiping with a cotton
swab. Migrating cells were fixed with 3.7 % paraformalde-
hyde in PBS, stainined with 0.04 % crystal violet, and
counted. Data represent means and standard deviations
from a single experiment, and were subject to two-way
analysis of variance, followed by the comparison by Stu-
dent’s t-test. P values obtained from the test are described
in the figure legends.
Additional files
Additional file 1: Table S1. Predictions for tyrosine phosphorylation of
ELMO1 were shown.
Additional file 2: Figure S1. Rac1 activity in cells with defective
tyrosine of ELMO1. Lysates from HEK293T cells transfected with
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pCXN2-Flag-Dock180 were subjected into pull-down assay for Rac1
activity.
Additional file 3: Movie S1. NIH3T3-Dock180-Control cells were
employed for cell spreading assay. The trypsinized cells were replaced
onto glass-based dishes coated with 10 μg/ml fibronectin. Immediately
after re-plating, DIC images of cells were obtained every one minutes for
1 h using a time-lapse imaging system.
Additional file 4: Movie S2. NIH3T3-Dock180-wild-type ELMO1 cells
were employed for cell spreading assay described in Additional file 3:
Movie S1, and movie of the DIC images were shown.
Additional file 5: Movie S3. NIH3T3-Dock180-ELMO1 Y724F cells were
employed for cell spreading assay described in Additional file 3: Movie S1,
and movie of the DIC images were shown.
Additional file 6: Figure S2. NIH3T3-ELMO1 cells were established by
infection of retroviruses bearing Control, ELMO1, and its Y724F mutant.
Expression levels of ELMO1 were examined by immunoblotting.
Additional file 7: Text S1. Materials and methods for Wound-healing
assay and Phagokinetic track assay were described.
Additional file 8: Figure S3. Wound-healing assay using NIH3T3-ELMO1
cells (A) and NIH3T3-Dock180-ELMO1 cells (B) are shown. Scale bars: 500 μm.
Additional file 9: Figure S4. ELMO1 pY724 facilitates cell migration. (A)
Analysis of cell motility by phagokinetic track assay. NIH3T3-Control, −wild-
type ELMO1, and -Y724F ELMO1 cells were placed onto gold particles-
mounted cover glasses coated with or without 10 μg/ml fibronectin.
Representative micrographs after incubation for 20 h are shown. (B) The
motility of the individual cells was evaluated by measuring the area cleared
of gold particles using MetaMorph software. The data are shown as
mean ± SD of 30 cells on each condition. *, P < 0.001; **, P < 0.0001; ***,
P < 0.0000001.
Additional file 10: Figure S5. Schematic representation of summary of
this study combined with previous findings. (A) Without Src activation.
SH3 domain of Dock180 intramolecularly binds to the Docker domain,
thereby preventing Rac from accessing to the Docker domain. (B) With
Src activation. In previous findings, following ECM adhesion such as
fibronectin, Src phosphorylates focal adhesion molecules such as p130Cas
and paxillin (black arrows), which leads to the recruitment of CRK/
Dock180 complex and subsequent Rac activation. Here, we identified
that Src directly phosphorylates ELMO1 at Y720 and Y724 residues (red
arrows), which enhances the interaction between ELMO1 and Dock180
via Pro-rich region and the SH3 domain, respectively. As RhoG has shown
to recruit ELMO1/Dock180 complex at plasma membrane, the facilitation
of ELMO1/Dock180 complex formation owing to the Src-dependent
pY720/pY724 of ELMO1 might be beneficial to rapid response to integrin
stimulation and highly polarized Rac activation, which contribute to
subsequent cell adhesion, spreading, and migration.
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